UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 1, 2011
IDENIX PHARMACEUTICALS, INC.
(Exact name of registrant as specified in its charter)
Delaware | 000-49839 | 45-0478605 | ||
(State or other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
60 Hampshire Street Cambridge, MA | 02139 | |
(Address of Principal Executive Offices) | (Zip Code) |
Registrant’s telephone number, including area code:(617) 995-9800
(Former name or former address if changed since last report.) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
1
Item 5.02. | Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers; Compensatory Arrangements of Certain Officers |
Targeted Shares | Targeted Shares | |||||||||||
Underlying Stock | Underlying Stock | |||||||||||
Named Executive | Options for fiscal | Options For fiscal | ||||||||||
Officer | Title | 2010 | 2011 | |||||||||
Ronald Renaud | President and Chief | 300,000 | 350,000 | |||||||||
Executive Officer | ||||||||||||
Daniella Beckman | Interim Chief Financial | N/A | N/A | |||||||||
Officer and Treasurer | ||||||||||||
Douglas Mayers | Executive Vice | 60,000 | 120,000 | |||||||||
President, Clinical | ||||||||||||
Development and | ||||||||||||
Chief Medical Officer | ||||||||||||
David Standring | Executive Vice | 50,000 | 120,000 | |||||||||
President and Chief | ||||||||||||
Scientific Officer | ||||||||||||
Maria Stahl | Senior Vice President | 80,000 | 100,000 | |||||||||
and General Counsel |
Date: April 6, 2011 | By: | /s/Maria Stahl | ||
Maria Stahl | ||||
Senior Vice President and General Counsel | ||||